Med-Tech Innovation April 21, 2021
Mobile health start-up iXensor explains how its company disrupted the conventional COVID-19 testing paradigm in Europe.
In October 2020, the European Commission issued a Recommendation on COVID-19 testing strategies, in which the use of rapid antigen tests was encouraged continuously as a way of strengthening countries’ testing capacity. The extent and intensity of these efforts vary from country to country and are constantly changing as the infection rates change and new technologies come into play.
The conventional COVID-19 testing deploys the PCR test, and the access to PCR tests is primarily limited to healthcare facilities and private medical labs. Its prolonged turnaround times, which take one to three days for reporting test results, can hinder the swift detection of...
Today's Sponsors
Today's Sponsor